Signal
Intu Diagnostics Secures 1.1 Million Euro Bridge Round for Lab-Free HPV Testing
- Category
- · Funding · Global
- Date
- July 1, 2026
- Source
- OVUM
Summary
Germany-based Fraunhofer spinout Intu Diagnostics has raised additional funding to advance its electricity-free, PCR-quality HPV diagnostic cartridge. The technology delivers results via color change in 30 minutes, removing infrastructure barriers for cervical cancer screening in underserved markets.
The company works in Oncology and Sexual & Reproductive, and this round is new money into that part of the market. Compare it with other recent rounds to see whether prices here are rising or holding steady.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.